Home » Topics » BioWorld Science

BioWorld Science
RSS

Cytotoxic compound eleutherobin reported by University of California

July 5, 1996

Glaxo Wellcome describes antitumor antibody conjugates

July 5, 1996

Antitumor vaccines described by University of Pennsylvania

July 5, 1996

Human Genome Sciences reports discovery of TNF-gamma

July 5, 1996

Pharmacia & Upjohn reports taxane derivatives

July 5, 1996

Dacliximab receives patent protection in U.S.

July 5, 1996

Pfizer's CJ-12798 claimed as immunosuppressant, antifungal and antitumor agent

July 5, 1996

MedImmune Lyme disease vaccine shows superior activity in animals

July 5, 1996

Immunostimulants claimed by Italfarmaco

July 5, 1996

Lidak reports discovery of antiinflammatory peptides

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.